Drug Regulator Asks 10 German Pharmas To Test Heparin Drugs
This article was originally published in PharmAsia News
Germany's drug regulator wants 10 of the nation's drug makers to test all batches of their heparin blood thinner. After earlier ordering a recall of the drug and asking companies to check the Chinese source of the active pharmaceutical ingredient, the German Federal Institute for Drugs and Medical Devices called for the additional tests. The German companies approached were not named. Rotexmedica GmbH, a German subsidiary of France's Groupe Panpharma, made the heparin recalled earlier. (Click here for more
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.